https://www.selleckchem.com/pr....oducts/orforglipron-
Mucopolysaccharidoses (MPS) are monogenic metabolic disorders that significantly affect the skeleton. Eleven enzyme defects in the lysosomal degradation of glycosaminoglycans (GAGs) have been assigned to the known MPS subtypes (I-IX). Arylsulfatase K (ARSK) is a recently characterised lysosomal hydrolase involved in GAG degradation that removes the 2-O-sulfate group from 2-sulfoglucuronate. Knockout of in mice was consistent with mild storage pathology, but no human phenotype has yet been described. In this study, we repo
Curtir
Comentario
Compartilhar
